Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies

Qian-Qian Liu; Zi-Kai Dong; Yong-Fei Wang; Wei-Lin Jin

doi:10.1186/s40779-025-00661-9

Your Location：

Home >

Browse articles >

Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies

REVIEW | Updated：2025-12-04

- Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies
- Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies
- “癌症神经科学是一门新兴的融合学科，它为神经系统与癌症进展之间的动态相互作用提供了新的见解。专家研究人员建立了神经-神经TME系统，该系统为解决癌症的关键特征问题提供了解决方案，为构建新的治疗策略奠定了基础。”
- Military Medical Research 2025年12卷
- Affiliations：
  
  1.Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, the First Hospital of Lanzhou University, the First Clinical Medical College of Lanzhou University, Lanzhou 730000, China
  2.State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China
- Author bio：
  
  * Wei-Lin Jin ldyy_jinwl@lzu.edu.cn
- Funds：
  
  High-Level Talent Introduction Funds from the First Hospital of Lanzhou University
- DOI：10.1186/s40779-025-00661-9
  中图分类号：
- 收稿：2025-03-27，
  
  录用：2025-10-11，
  
  网络首发：2025-10-30，
  
  纸质出版：2025
- Accepted：
Scan QR Code
Qian-Qian Liu, Zi-Kai Dong, Yong-Fei Wang, 等. Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies[J/OL]. Military Medical Research, 2025,12.

Qian-Qian Liu, Zi-Kai Dong, Yong-Fei Wang, et al. Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies[J/OL]. Military Medical Research, 2025, 12.
Qian-Qian Liu, Zi-Kai Dong, Yong-Fei Wang, 等. Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies[J/OL]. Military Medical Research, 2025,12. DOI： 10.1186/s40779-025-00661-9.

Qian-Qian Liu, Zi-Kai Dong, Yong-Fei Wang, et al. Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies[J/OL]. Military Medical Research, 2025, 12. DOI： 10.1186/s40779-025-00661-9.

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies

Applications and prospects of cryo-EM in drug discovery

The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer

Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer

摆式列车线路检测信号的动态自适应滤波研究

Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies

Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies

DOI：10.1186/s40779-025-00661-9